Melatonina Mylan (Melatonin)

Melatonin acts as an agonist at MT1 and MT2 receptors located in the brain’s suprachiasmatic nucleus. By binding these receptors, it mimics the natural nighttime signal, helping to shift the internal clock, promote sleep onset, and stabilize the timing of the circadian rhythm without directly causing sedation.

The appropriate dose of Melatonina Mylan is determined by a qualified healthcare professional based on the individual’s age, condition, and response. Prescribers select the strength and dosing schedule that best fits the patient’s specific sleep‑related needs.

Safety data for melatonin use in pregnancy and lactation are limited. It is generally recommended to avoid routine use unless the potential benefit outweighs any possible risk, and this decision should be made in consultation with a healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Unlike prescription hypnotics that act on GABA receptors, melatonin works by aligning the body’s internal clock. It is available over the counter, has a different side‑effect profile, and is generally considered safer for short‑term use, though efficacy may vary depending on the underlying sleep disorder.

Melatonina Mylan should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat, and direct sunlight to maintain potency throughout its shelf life.

The product is taken orally, typically with a glass of water. It is usually recommended to ingest the dose about 30‑60 minutes before the desired bedtime, following the specific timing instructions provided by the prescribing clinician.

Serious but rare risks include severe allergic reactions such as rash, itching, or angioedema, as well as significant mood changes like depression or irritability. Any signs of an allergic response or unexpected psychological symptoms should prompt immediate medical evaluation.

Individuals with known hypersensitivity to melatonin or any excipients in the formulation should avoid use. Additionally, patients taking certain anticoagulants, strong CYP1A2 inhibitors, or those with uncontrolled autoimmune conditions should consult a healthcare professional before starting therapy.